Well with all of what’s happened with the BOD and delisting, hopefully they comment directly on what’s been going on.
I just can’t see this just fizzling away in bankruptcy with nothing to show for Lenz. Way to much potential for the drug, there has to be something more but at this point the market doesn’t seem to think so.